Comparison between Earum Pharmaceuticals IPO and Wonder Fibromats IPO.
IPO Details
Earum Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while Wonder Fibromats IPO is a SME Fixed Price proposed to list at NSE SME.
The total issue size of Earum Pharmaceuticals IPO is up to ₹6.31 Cr whereas the issue size of the Wonder Fibromats IPO is up to ₹18.80 Cr. The final issue price of Earum Pharmaceuticals IPO is ₹36.00 per share and of Wonder Fibromats IPO is ₹89.00 per share.
Earum Pharmaceuticals IPO opens on Jun 21, 2019, while Wonder Fibromats IPO opens on Jul 22, 2019. The closing date of Earum Pharmaceuticals IPO and Wonder Fibromats IPO is Jun 26, 2019, and Jul 29, 2019, respectively.
In the Earum Pharmaceuticals IPO Retail Individual Investors (RII) are offered 8,76,000 shares while in Wonder Fibromats IPO retail investors are offered 8,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Earum Pharmaceuticals IPO and in Wonder Fibromats IPO.